Financhill
Back

Kiniksa Pharmaceuticals Vs. EPAM Systems Industry Stock Comparison

Buy
65

KNSA
Kiniksa Pharmaceuticals

Last Price:
19.84
Seasonality Move:
6.55%
Sell
12

EPAM
EPAM Systems

Last Price:
190.28
Seasonality Move:
15.98%
Buy
65
Kiniksa Pharmaceuticals (KNSA) is a Buy

Is Kiniksa Pharmaceuticals a Buy, Sell or Hold?

  • The current Kiniksa Pharmaceuticals [KNSA] share price is $19.77. The Score for KNSA is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • KNSA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
12
EPAM Systems (EPAM) is a Sell

Is EPAM Systems a Buy, Sell or Hold?

  • The current EPAM Systems [EPAM] share price is $187.80. The Score for EPAM is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • EPAM is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

KNSA Stock Price Chart

What is Kiniksa Pharmaceuticals's stock price today?

  • The Kiniksa Pharmaceuticals share price today is $19.77
    The current trend is moderately bullish and KNSA is experiencing selling pressure, which indicates risk of future bearish movement.

EPAM Stock Price Chart

What is EPAM Systems's stock price today?

  • The EPAM Systems share price today is $187.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EPAM is experiencing buying pressure, which is a positive indicator for future bullish movement.

KNSA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.4 Buy
Relative Strength Index (14 RSI): 57.46 Buy
Chaikin Money Flow: -201585 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.54 - 20) Buy
Bollinger Bands (100): (18.01 - 20.25) Buy

EPAM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -19.69 Sell
Relative Strength Index (14 RSI): 25.03 Sell
Chaikin Money Flow: 631864 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (202.18 - 254.46) Sell
Bollinger Bands (100): (242.9 - 307.72) Sell

KNSA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.88 Sell
20-day SMA: 19.18 Buy
50-day SMA: 19.01 Buy
200-day SMA: 17.93 Buy
8-day EMA: 19.8 Sell
20-day EMA: 19.37 Buy
50-day EMA: 19.08 Buy
200-day EMA: 17.84 Buy

EPAM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 194.97 Sell
20-day SMA: 223 Sell
50-day SMA: 254.73 Sell
200-day SMA: 263.49 Sell
8-day EMA: 197.78 Sell
20-day EMA: 217.98 Sell
50-day EMA: 244.52 Sell
200-day EMA: 267.04 Sell

Kiniksa Pharmaceuticals Earnings Growth & KNSA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and an increase next year of $0.49 per share.

EPAM Systems Earnings Growth & EPAM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.24 per share, and an increase next year of $1.15 per share.

Kiniksa Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

EPAM Systems Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):